Where Discovery Begins
H_BCMA Reporter 293 Cell Line
Cat. No.
GM-C44705
Size
2 vial
Quote
Description
Data Display
Specifications
Materials
Cell Culture
Related products
Description
BCMA (B-cell maturation antigen) is a protein expressed on mature B cells and plasma cells, regulating their survival, proliferation, and differentiation. It is crucial in B cell-related diseases, particularly multiple myeloma (MM), where its levels are elevated, making it a key therapeutic target.

The BCMA signaling pathway is mainly activated by binding to its ligands (such as APRIL and BAFF), which triggers downstream signal transduction. The activation of BCMA can promote the survival and proliferation of B cells through signaling pathways such as NF-κB, MAPK, and PI3K/Akt. The activation of these signaling pathways not only aids in the development and function of B cells but is also closely related to the survival and drug resistance of tumor cells.

H_BCMA Reporter 293 Cell Line is a clonal stable 293 cell line constructed using lentiviral technology, constitutive expression of the BCMA gene, along with signal-dependent expression of a luciferase reporter gene. When Ligand binds to BCMA, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to BCMA.
BCMA (B-cell maturation antigen) is a protein expressed on mature B cells and plasma cells, regulating their survival, proliferation, and differentiation. It is crucial in B cell-related diseases, particularly multiple myeloma (MM), where its levels are elevated, making it a key therapeutic target.

The BCMA signaling pathway is mainly activated by binding to its ligands (such as APRIL and BAFF), which triggers downstream signal transduction. The activation of BCMA can promote the survival and proliferation of B cells through signaling pathways such as NF-κB, MAPK, and PI3K/Akt. The activation of these signaling pathways not only aids in the development and function of B cells but is also closely related to the survival and drug resistance of tumor cells.

H_BCMA Reporter 293 Cell Line is a clonal stable 293 cell line constructed using lentiviral technology, constitutive expression of the BCMA gene, along with signal-dependent expression of a luciferase reporter gene. When Ligand binds to BCMA, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to BCMA.
Data Display
Signaling Pathway
Response to Human BAFF Protein; His Tag. The H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) at a density of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human BAFF Protein; His Tag(Cat. GM-87735RP) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [299.5]. Data are shown by drug mass concentration.
Response to Recombinant Human APRIL (N-Flag-His). The H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) at a density of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human APRIL (N-Flag-His)(Novoprotein/CU89) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [180.2]. Data are shown by drug mass concentration.
Response to Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line. H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line (Cat. GM-C40503) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech).
Applications
Inhibition of BAFF Protein-induced reporter activity by Belantamab. H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of the Anti-BCMA hIgG1 Antibody(Cat. GM-52396AB) was incubated with 1.5E4 cells/well of the H_BCMA Reporter 293 Cell Line in a 96-well plate for 1 hour in assay buffer. Subsequently, the Human BAFF Protein (Cat. GM-87735RP) at a density of 50 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
Inhibition of Membrane Bound H_APRIL(Trimer) 293-induced reporter activity by Sibeprenlimab. The H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of the Anti-APRIL hIgG2 Reference Antibody (Sibebio) (Cat. GM-88014MAB) and 1E4 cells/well of the Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line (Cat. GM-C40503) were added to 1.5E4 cells/well of H_BCMA Reporter 293 Cell Line(Cat. GM-C44705) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis. Data are shown by drug mass concentration.
Inhibition of BAFF Protein-induced reporter activity by Belimumab.H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio) (Cat. GM-87985MAB) was incubated with 50 ng/well of Human BAFF Protein(Cat. GM-87735RP) for 1 hour in assay buffer. After pre-incubation, add to the pre-seeded cells, and incubate for 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis. Data are shown by drug mass concentration.
Inhibition of BAFF Protein-induced reporter activity by SEA-BCMA. H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of the Anti-BCMA hIgG1 Antibody(SEA-BCMA)(Cat. GM-49486AB) was incubated with 1.5E4 cells/well of the H_BCMA Reporter 293 Cell Line in a 96-well plate for 1 hour in assay buffer. Subsequently, the Human BAFF Protein (Cat. GM-87735RP) at a density of 50 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
Belantamab inhibits membrane-bound H_APRIL(Trimer)-induced reporter activity in H_BCMA Reporter 293 cells. The H_BCMA Reporter 293 (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, H_BCMA Reporter 293 Cells were incubated with serial dilutions of Anti-BCMA hIgG1 Antibody(Cat. GM-52396AB) (S1–S4: 1.5‑fold from 200 μg/mL; S4–S10: 5‑fold from 59.26 μg/mL) for 1 hours, then co‑cultured with Membrane Bound H_APRIL(Trimer) HEK-293(Cat. GM-C40503) for 6  hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech) (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
SEA-BCMA inhibits membrane-bound H_APRIL(Trimer)-induced reporter activity in H_BCMA Reporter 293 cells. The H_BCMA Reporter 293 (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, H_BCMA Reporter 293 Cells were incubated with serial dilutions of Anti-BCMA hIgG1 Antibody(SEA-BCMA) (Cat. GM-49486AB) (S1–S4: 1.5‑fold from 200 μg/mL; S4–S10: 5‑fold from 59.26 μg/mL) for 1 hours, then co‑cultured with Membrane Bound H_APRIL(Trimer) HEK-293(Cat. GM-C40503) for 6  hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech) (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
Expression
H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was determined by flow cytometry using Anti-BCMA hIgG1 Antibody(Cat. GM-52396AB).
Specifications
Cat. No GM-C44705
Product H_BCMA Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C44705
Product H_BCMA Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Materials
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line Genomeditech/GM-C40503
Human BAFF Protein; His Tag Genomeditech/GM-87735RP
Recombinant Human APRIL (N-Flag-His) Novoprotein/CU89
Anti-BCMA hIgG1 Antibody Genomeditech/GM-52396AB
Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio) Genomeditech/GM-87985MAB
Anti-APRIL hIgG2 Reference Antibody (Sibebio) Genomeditech/GM-88014MAB
Anti-BCMA hIgG1 Antibody(SEA-BCMA) Genomeditech/GM-49486AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line Genomeditech/GM-C40503
Human BAFF Protein; His Tag Genomeditech/GM-87735RP
Recombinant Human APRIL (N-Flag-His) Novoprotein/CU89
Anti-BCMA hIgG1 Antibody Genomeditech/GM-52396AB
Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio) Genomeditech/GM-87985MAB
Anti-APRIL hIgG2 Reference Antibody (Sibebio) Genomeditech/GM-88014MAB
Anti-BCMA hIgG1 Antibody(SEA-BCMA) Genomeditech/GM-49486AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Related products
CD40:CD40L
H_CD40(TNFRSF5) Reporter 293 Cell Line H_CD40(TNFRSF5) Reporter Jurkat Cell Line Cynomolgus_CD40 CHO-K1 Cell Line
Cynomolgus_CD40L CHO-K1 Cell Line H_CD40(TNFRSF5) CHO-K1 Cell Line H_CD40(TNFRSF5) HEK-293 Cell Line
H_CD40L CHO-K1 Cell Line H_CD40L HEK-293 Cell Line Mouse_CD40L CHO-K1 Cell Line
Rabbit_CD40L NIH-3T3 Cell Line
Biotinylated Human CD40 Protein; His-Avi Tag Cynomolgus CD40 Protein; His Tag Human CD40 Protein; His Tag
Human CD40L Protein; His Tag    
IFN-α
IFNα Reporter HEK-293 Cell Line IFNα Reporter MDCK Cell Line IFNα Reporter THP1 Cell Line
BCMA:BAFFR:TACI
H_BAFFR Jurkat Blockade Reporter Cell Line H_BAFFR Reporter Cell Line H_BCMA Reporter Cell Line
H_TACI Reporter Cell Line Cynomolgus_BCMA CHO-K1 Cell Line (Low Expression) Cynomolgus_BCMA HEK-293 Cell Line
H_BAFFR CHO-K1 Cell Line H_BAFFR HEK-293 Cell Line H_BCMA CHO-K1 Cell Line (Low Expression)
H_BCMA HEK-293 Cell Line Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line
Biotinylated Human BAFF Protein; His-Avi Tag Biotinylated Human BCMA Protein; His-Avi Tag Cynomolgus BAFF Protein; His Tag
Cynomolgus BCMA Protein; hFc Tag Cynomolgus BCMA Protein; His Tag Human APRIL Protein; hFc Tag
Human BCMA Protein; hFc Tag Human BCMA Protein; His Tag Mouse BAFF Protein; His Tag
BDCA2(CLEC4C)
H_BDCA2 Reporter DDX35TM Jurkat Cell Line H_BDCA2 Reporter Jurkat Cell Line Cynomolgus_BDCA2 CHO-K1 Cell Line
Cynomolgus_BDCA2 Jurkat Cell Line H_BDCA2 CHO-K1 Cell Line H_BDCA2 HEK-293 Cell Line
H_BDCA2 Jurkat Cell Line
Cynomolgus BDCA2 Protein; His Tag Human BDCA2 Protein; His Tag  
CD3
Cynomolgus_CD3D CD3E Reporter Jurkat(CD3DE KO) Cell Line Jurkat CD3-BsAb Reporter Cell Line Cynomolgus_CD3 HEK-293 Cell Line
Cynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line H_CD3 CHO-K1 Cell Line H_CD3 HEK-293 Cell Line
H_CD3(TCR V2) CHO-K1 Cell Line H_CD3(TCR V2) HEK-293 Cell Line H_CD3(TCRαβ delta V) HEK-293 Cell Line
H_CD3D CD3E KO Jurkat Cell Line H_CD3E KO Jurkat Cell Line H_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line    
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_BCMA Reporter 293 Cell Line
H_BCMA Reporter 293 Cell Line
Cat. No.
GM-C44705
Size
2 vial
Quote
Description
Data Display
Specifications
Materials
Cell Culture
Related products
Description
BCMA (B-cell maturation antigen) is a protein expressed on mature B cells and plasma cells, regulating their survival, proliferation, and differentiation. It is crucial in B cell-related diseases, particularly multiple myeloma (MM), where its levels are elevated, making it a key therapeutic target.

The BCMA signaling pathway is mainly activated by binding to its ligands (such as APRIL and BAFF), which triggers downstream signal transduction. The activation of BCMA can promote the survival and proliferation of B cells through signaling pathways such as NF-κB, MAPK, and PI3K/Akt. The activation of these signaling pathways not only aids in the development and function of B cells but is also closely related to the survival and drug resistance of tumor cells.

H_BCMA Reporter 293 Cell Line is a clonal stable 293 cell line constructed using lentiviral technology, constitutive expression of the BCMA gene, along with signal-dependent expression of a luciferase reporter gene. When Ligand binds to BCMA, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to BCMA.

BCMA (B-cell maturation antigen) is a protein expressed on mature B cells and plasma cells, regulating their survival, proliferation, and differentiation. It is crucial in B cell-related diseases, particularly multiple myeloma (MM), where its levels are elevated, making it a key therapeutic target.

The BCMA signaling pathway is mainly activated by binding to its ligands (such as APRIL and BAFF), which triggers downstream signal transduction. The activation of BCMA can promote the survival and proliferation of B cells through signaling pathways such as NF-κB, MAPK, and PI3K/Akt. The activation of these signaling pathways not only aids in the development and function of B cells but is also closely related to the survival and drug resistance of tumor cells.

H_BCMA Reporter 293 Cell Line is a clonal stable 293 cell line constructed using lentiviral technology, constitutive expression of the BCMA gene, along with signal-dependent expression of a luciferase reporter gene. When Ligand binds to BCMA, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to BCMA.

Data Display
Signaling Pathway
Response to Human BAFF Protein; His Tag. The H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) at a density of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human BAFF Protein; His Tag(Cat. GM-87735RP) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [299.5]. Data are shown by drug mass concentration.
Response to Recombinant Human APRIL (N-Flag-His). The H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) at a density of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Human APRIL (N-Flag-His)(Novoprotein/CU89) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [180.2]. Data are shown by drug mass concentration.
Response to Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line. H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line (Cat. GM-C40503) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech).
Applications
Inhibition of BAFF Protein-induced reporter activity by Belantamab. H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of the Anti-BCMA hIgG1 Antibody(Cat. GM-52396AB) was incubated with 1.5E4 cells/well of the H_BCMA Reporter 293 Cell Line in a 96-well plate for 1 hour in assay buffer. Subsequently, the Human BAFF Protein (Cat. GM-87735RP) at a density of 50 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
Inhibition of Membrane Bound H_APRIL(Trimer) 293-induced reporter activity by Sibeprenlimab. The H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of the Anti-APRIL hIgG2 Reference Antibody (Sibebio) (Cat. GM-88014MAB) and 1E4 cells/well of the Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line (Cat. GM-C40503) were added to 1.5E4 cells/well of H_BCMA Reporter 293 Cell Line(Cat. GM-C44705) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis. Data are shown by drug mass concentration.
Inhibition of BAFF Protein-induced reporter activity by Belimumab.H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio) (Cat. GM-87985MAB) was incubated with 50 ng/well of Human BAFF Protein(Cat. GM-87735RP) for 1 hour in assay buffer. After pre-incubation, add to the pre-seeded cells, and incubate for 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis. Data are shown by drug mass concentration.
Inhibition of BAFF Protein-induced reporter activity by SEA-BCMA. H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, Serial dilutions of the Anti-BCMA hIgG1 Antibody(SEA-BCMA)(Cat. GM-49486AB) was incubated with 1.5E4 cells/well of the H_BCMA Reporter 293 Cell Line in a 96-well plate for 1 hour in assay buffer. Subsequently, the Human BAFF Protein (Cat. GM-87735RP) at a density of 50 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech). (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
Belantamab inhibits membrane-bound H_APRIL(Trimer)-induced reporter activity in H_BCMA Reporter 293 cells. The H_BCMA Reporter 293 (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, H_BCMA Reporter 293 Cells were incubated with serial dilutions of Anti-BCMA hIgG1 Antibody(Cat. GM-52396AB) (S1–S4: 1.5‑fold from 200 μg/mL; S4–S10: 5‑fold from 59.26 μg/mL) for 1 hours, then co‑cultured with Membrane Bound H_APRIL(Trimer) HEK-293(Cat. GM-C40503) for 6  hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech) (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
SEA-BCMA inhibits membrane-bound H_APRIL(Trimer)-induced reporter activity in H_BCMA Reporter 293 cells. The H_BCMA Reporter 293 (Cat. GM-C44705) was seeded at a density of 1.5E4 cells per well in a 96-well plate and incubated overnight. The next day, H_BCMA Reporter 293 Cells were incubated with serial dilutions of Anti-BCMA hIgG1 Antibody(SEA-BCMA) (Cat. GM-49486AB) (S1–S4: 1.5‑fold from 200 μg/mL; S4–S10: 5‑fold from 59.26 μg/mL) for 1 hours, then co‑cultured with Membrane Bound H_APRIL(Trimer) HEK-293(Cat. GM-C40503) for 6  hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech) (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis.
Expression
H_BCMA Reporter 293 Cell Line (Cat. GM-C44705) was determined by flow cytometry using Anti-BCMA hIgG1 Antibody(Cat. GM-52396AB).
Specifications
Cat. No GM-C44705
Product H_BCMA Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C44705
Product H_BCMA Reporter 293 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Materials
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line Genomeditech/GM-C40503
Human BAFF Protein; His Tag Genomeditech/GM-87735RP
Recombinant Human APRIL (N-Flag-His) Novoprotein/CU89
Anti-BCMA hIgG1 Antibody Genomeditech/GM-52396AB
Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio) Genomeditech/GM-87985MAB
Anti-APRIL hIgG2 Reference Antibody (Sibebio) Genomeditech/GM-88014MAB
Anti-BCMA hIgG1 Antibody(SEA-BCMA) Genomeditech/GM-49486AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
DMEM Gibco/C11995500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line Genomeditech/GM-C40503
Human BAFF Protein; His Tag Genomeditech/GM-87735RP
Recombinant Human APRIL (N-Flag-His) Novoprotein/CU89
Anti-BCMA hIgG1 Antibody Genomeditech/GM-52396AB
Anti-TNFSF13B(BAFF) hIgG1 Reference Antibody (Belibio) Genomeditech/GM-87985MAB
Anti-APRIL hIgG2 Reference Antibody (Sibebio) Genomeditech/GM-88014MAB
Anti-BCMA hIgG1 Antibody(SEA-BCMA) Genomeditech/GM-49486AB
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+0.75 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Related products
CD40:CD40L
H_CD40(TNFRSF5) Reporter 293 Cell Line H_CD40(TNFRSF5) Reporter Jurkat Cell Line Cynomolgus_CD40 CHO-K1 Cell Line
Cynomolgus_CD40L CHO-K1 Cell Line H_CD40(TNFRSF5) CHO-K1 Cell Line H_CD40(TNFRSF5) HEK-293 Cell Line
H_CD40L CHO-K1 Cell Line H_CD40L HEK-293 Cell Line Mouse_CD40L CHO-K1 Cell Line
Rabbit_CD40L NIH-3T3 Cell Line
Biotinylated Human CD40 Protein; His-Avi Tag Cynomolgus CD40 Protein; His Tag Human CD40 Protein; His Tag
Human CD40L Protein; His Tag    
IFN-α
IFNα Reporter HEK-293 Cell Line IFNα Reporter MDCK Cell Line IFNα Reporter THP1 Cell Line
BCMA:BAFFR:TACI
H_BAFFR Jurkat Blockade Reporter Cell Line H_BAFFR Reporter Cell Line H_BCMA Reporter Cell Line
H_TACI Reporter Cell Line Cynomolgus_BCMA CHO-K1 Cell Line (Low Expression) Cynomolgus_BCMA HEK-293 Cell Line
H_BAFFR CHO-K1 Cell Line H_BAFFR HEK-293 Cell Line H_BCMA CHO-K1 Cell Line (Low Expression)
H_BCMA HEK-293 Cell Line Membrane Bound H_APRIL(Trimer) HEK-293 Cell Line
Biotinylated Human BAFF Protein; His-Avi Tag Biotinylated Human BCMA Protein; His-Avi Tag Cynomolgus BAFF Protein; His Tag
Cynomolgus BCMA Protein; hFc Tag Cynomolgus BCMA Protein; His Tag Human APRIL Protein; hFc Tag
Human BCMA Protein; hFc Tag Human BCMA Protein; His Tag Mouse BAFF Protein; His Tag
BDCA2(CLEC4C)
H_BDCA2 Reporter DDX35TM Jurkat Cell Line H_BDCA2 Reporter Jurkat Cell Line Cynomolgus_BDCA2 CHO-K1 Cell Line
Cynomolgus_BDCA2 Jurkat Cell Line H_BDCA2 CHO-K1 Cell Line H_BDCA2 HEK-293 Cell Line
H_BDCA2 Jurkat Cell Line
Cynomolgus BDCA2 Protein; His Tag Human BDCA2 Protein; His Tag  
CD3
Cynomolgus_CD3D CD3E Reporter Jurkat(CD3DE KO) Cell Line Jurkat CD3-BsAb Reporter Cell Line Cynomolgus_CD3 HEK-293 Cell Line
Cynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line H_CD3 CHO-K1 Cell Line H_CD3 HEK-293 Cell Line
H_CD3(TCR V2) CHO-K1 Cell Line H_CD3(TCR V2) HEK-293 Cell Line H_CD3(TCRαβ delta V) HEK-293 Cell Line
H_CD3D CD3E KO Jurkat Cell Line H_CD3E KO Jurkat Cell Line H_CD3E(Membrane Bound ECD) CHO-K1 Cell Line
Mouse_CD3 HEK-293 Cell Line    
Contact
Us
Message Inquiry
reset
submit
Message
Message Inquiry
reset
submit